Efficacy and safety of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in retreatment of patients without T790M

Category Primary study
JournalTransl. Lung Cancer Res.
Year 2025
This article has no abstract
Epistemonikos ID: a96cb2359f37797b7ad2ef6f270a15424b90c981
First added on: Sep 03, 2025